Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
With this design, this study hypothesizes that; (i) ICG-PDT would produce superior clinical,
microbiological, and immune-inflammatory outcomes as compared to RSD and (ii) ICG-PDT would
produce equal efficacy among different forms of diabetes as produced in non-diabetic subjects
and that diabetes mellitus would not produce negative impact on the therapeutic outcomes of
ICG-PDT. Therefore, the aim of this randomized controlled clinical trial was to evaluate the
efficacy of ICG-mediated aPDT in the treatment of stage III grade C periodontitis among
patients with prediabetes, T2DM and non-diabetic subjects.